-
Date: November 22, 2010Roundtable ID: CV4149Citation: Med Roundtable Cardiovasc Ed. ; 2(1): 7 - 13.
Implications of EMPHASIS-HF for Clinical Practice
Moderator:
There is no moderator for this particular article.
Discussants:
There are no discussants for this particular article.
-
Summary:
Dr. Marc Pfeffer from Brigham and Women's Hospital of Harvard University moderated the topic "Implications of EMPHASIS-HF for Clinical Practice" with Drs. Bertram Pitt from the University of Michigan and Faiez Zannad from the University of Nancy, France participating.
- The discussion focused primarily on:
- (1) the RALES trial,
- (2) effects of combining spironolactone and ACE inhibtors on renal function,
- (3) the CONSENSUS trial,
- (4) US physician concern over use of spironolactone and hyperkalemia,
- (5) European experience with effective spironolactone therapy,
- (6) comparison btween eplerenone and spironolactone, and
- (7) the findings of EMPHASIS-HF trial including considerations surrounding ending the trial early.
- (Med Roundtable Cardiovasc Ed. 2011;2(1):7-13) ©2011 FoxP2 Media, LLC
-
Compounds:Trials:
CONSENSUS I, EPHESUS, EMPHASIS-HF, RALES, TOPCAT
Please subscribe to use our print features or to download PDF files.